Records containing: Migraine Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-23Kan Uddannelse i søvnhygiejne Forbedre søvnkvalitet for Patienter Med Kroniske Smerter?
-
CLINICAL_TRIALS study record update · 2026-02-05Influence of Aerobic Exercise on Sensory Perception, Musculoskeletal and Psychosocial Alterations in Patients With Migraine
-
CLINICAL_TRIALS study record update · 2026-01-30Yogabaserade övningar Som Kompletterande Behandling Vid migrän Och/Eller klusterhuvudvärk YOURHEAD - a Pilot Study
-
CLINICAL_TRIALS study record update · 2026-01-16Yogabased Movements Weekly (Online Live or Face to Face) for Primary Headaches
-
CLINICAL_TRIALS study record update · 2025-07-31A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-13Effectiveness of Tai Chi and Acupuncture in the Prophylaxes of Episodic Migraine in Hong Kong Chinese Women and the Analysis of Microstructural White Matter Alterations: a Non-inferiority Single-blind Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-03-18Neurophysiological and Biomolecular Effects of Atogepant in High Frequency Episodic Migraine (ATOM Project)
-
CLINICAL_TRIALS study record update · 2022-05-19A Pilot Randomized Controlled Trial to Test the Complementary Therapeutic Efficacy of Tai Chi for the Prophylaxis of Episodic Migraine in Chinese Women
-
CLINICAL_TRIALS study record update · 2020-04-21An Open Label Phase 3 Trial to Evaluate the Safety of ALD403 Administered Intravenously in Patients With Chronic Migraines